Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WOMEN&More weekly mifepristone contraception study
2022-502694-41-00Phase 3Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone in contraception, sponsored by Leiden University Medical Center. Planned start Apr 2025; status: authorised.
02
Drugs
mifepristone
03
Conditions
contraception
Beyond the preview
Go deeper on 2022-502694-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502694-41-00.